
==== Front
Int J Emerg Med
Int J Emerg Med
International Journal of Emergency Medicine
1865-1372
1865-1380
Springer Berlin Heidelberg Berlin/Heidelberg

39251910
707
10.1186/s12245-024-00707-0
Case Report
Posterior reversible encephalopathy syndrome (PRES) on the second postpartum day: learning experience from a case report and literature review
https://orcid.org/0000-0003-2915-7098
Vuong Anh Dinh Bao 1
https://orcid.org/0000-0002-2037-8591
Pham Xuan Trang Thi 1
https://orcid.org/0000-0001-6473-7755
Nguyen Phuc Nhon docternhon@gmail.com

12
1 Department of High-risk Pregnancy, Tu Du Hospital, 284 Cong Quynh, Pham Ngu Lao ward, District 1, Ho Chi Minh City, 71012 Vietnam
2 Tu Du Clinical Research Unit (TD-CRU), Tu Du Hospital, Ho Chi Minh City, Vietnam
9 9 2024
9 9 2024
2024
17 11819 6 2024
2 9 2024
© The Author(s) 2024
2024
https://creativecommons.org/licenses/by-nc-nd/4.0/ Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
Background

Posterior reversible encephalopathy syndrome (PRES) is an uncommon neurological disorder which is characterised by variable symptoms. The transient clinical condition may be underestimated and misdiagnosed as other conditions, especially, among pregnant women with severe preeclampsia, eclampsia, and HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome in the puerperium. We hereby contribute to the literature this rare complication and hightlight the appropriate management of PRES .

Presentation case

A pregnant woman (gravida 3, parity 2) had a normal antenatal course. However, she was diagnosed with severe preeclampsia and HELLP syndrome at 29 weeks and 5 days of gestation. Therefore, she was indicated for a medical termination of pregnancy following a patient’s consent at our tertiary referral hospital. Severely, the patient developed rapidly with altered mental health in early puerperium. In result, PRES was diagnosed based on a brain magnetic resonance imaging (MRI) evidence with typical findings. After a strict multidisciplinary management, the clinical condition improved after 5 days of onset and recovered completely after a 4-month follow-up without any sequelae.

Conclusion

In summary, despite its rarity, clinicians ought to be knowledgeable and raise an aware of PRES during pregnancy. Importantly, a brain imaging modalities should be taken into account among pregnant women with neurological symptoms subsequent to severe preeclampsia. In addition to early diagnosis, a timely appropriate treatment with multidisciplinary team is strongly indicated. Further studies with a large case series are required for this uncommon entity.

Keywords

HELLP syndrome
Maternal mortality
MRI
Neurology
Preeclampsia
PRES
issue-copyright-statement© Springer-Verlag GmbH Germany, part of Springer Nature 2024
==== Body
pmcIntroduction

Posterior reversible encephalopathy syndrome (PRES), also known as reversible posterior leukoencephalopathy syndrome defined as the clinical-neuro-radiological disorder of the brain [1, 2]. This rare syndrome may be observed in pregnant women and non-pregnant women. In general, the pathology develops with pregnancy-related hypertensive disorders during the antepartum or postpartum course. The incidence of PRES during pregnancy has not yet been documented. This syndrome was noted in young women and the primigravida is more related to PRES [3].

Among severe forms of preeclampsia, PRES relates to endothelial dysfunction accompanying with disruption in the blood-brain barrier resulting in cerebral edema, vasogenic edema, and cerebrovascular autoregulatory dysfunction [1]. Nevertheless, among patients without preeclampsia, underlying pathophysiology remains unknown. Other conditions could induce the onset of PRES including systemic lupus erythematosus, chronic renal failure, rheumatoid arthritis, immune suppressive medications, anti-neoplastic agents, severe hypercalcemia, thrombocytopenic syndromes, Henoch-Schonlein purpura, hemolytic uremic syndrome, amyloid angiopathy, various causes of renal failure, regional anesthesia, sepsis, toxic agents, especially chemotherapy, and drugs such as cocaine, methamphetamine [4, 5].

The clinical manifestations of PRES develop secondary to cerebral edema and is associated with various clinical conditions [6]. According to Wen et al., the common symptoms were headache (81%), generalized tonic-clonic seizures (73%), altered mental status (57%), nausea/vomiting (47%) and visual disturbance (33%) [7].

According to hallmark signs, cranial radiologic evidence shows cerebral edema in the posterior parts of the brain. The lesions encounter parieto-occipital white matter changes with vasogenic edema. Computed tomography scan (CT scan) and magnetic resonance imaging (MRI) plays a potential role in assessing this syndrome [8, 9]. Typical findings include reversible, symmetrical, posterior subcortical vasogenic edema [10]. An early diagnosis helps in a timely treatment. An appropriate management facilitates the favorable outcomes and reduces the recovery time without a sequelae [1]. However, the data concerning PRES among pregnant women in postpatum course are still limited [7, 11]. Herein, we report a rare case of PRES in a pregnant woman after an early termination of pregnancy with a successful management.

Presentation case

A 31-year-old pregnant woman (gravida 3 parity 2) was transferred to our tertiary referral hospital due to HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome subsequent to severe preeclampsia. According to the estimated due date of ultraound in the first trimester, the gestation age was 29 weeks and 5 days. Her obstetric history was uneventful with two vaginal births. The patient denied to have a high blood pressure before and during this pregnancy as well as other diseases and the use of drugs. At the local hospital, her blood pressure was measured at 200/120 mmHg. Immediately, the patient was given with antihypertensive drug by intravenous (IV) infusion of nicardipine (10 mg/10 ml) along with 40 ml glucose 5%. A 5-ml bolus dosage was administered and IV infusion of 7.5 ml/h was maintained. Her blood pressure was checked every 30 min to avoid the pharmacological-induced hypotension. The patient was recorded with dyspnea and the respiratory frequencies were noted 23 times per minute. The peripheral oxygen saturation (SPO2) was 93% and increased to 98% by mask-delivered oxygen therapy setting at 6–8 L per minute. Her pulse rate was 90 beats per minute. Her body temperature was 37 degrees Celsius. The urine bag collected approximately 80 ml of transparent yellow urine in 3 h. The patient complained of mild headache and epigastric pain. Her vision was normal. Five days before hospitalization, the patient was recorded with cough up phlegm. The color of mucus was clearly green without blood. This symptom appeared before the new onset of hypertension. Pulmonary auscultation was noted with decreased bronchial breath sounds, crackles, and egophony. The pneumonia was initially suspected, however the pulmonary edema could not also be excluded completely.

During hospitalization, her vital signs were remarkable (Table 1). Edema was found in the lower limbs. The patient was administered extensively with nicardipine for hypertensive management and magnesium sulfate (MgSO4) for prevention of eclamptic seizures. Both continuous intravenous medicaments were administered using an electronically controlled infusion pump. At admission, the assessment of renal function test was normal, except for a serum acid uric of 509 (µmol/l). The lactate dehydrogenase (LDH) concentration was measured at 2514 U/L. Glycemia was normal. The coagulation profile showed a weakly contractile blood clot. Other laboratory tests are shown in Table 1. The transmitted disease tests including hepatitis B surface antigen (HBsAg), human immunodeficiency virus infection (HIV), and treponema pallidum test were negative. Her uterine parameters showed proteinuria of 3.0 g/l, albumin > 150 mg/l, albumin/creatinine ratio ≥ 33.9 (16.95) mg/mmol, and protein/creatinine ratio ≥ 55 mg/mmol. Ultrasound scan showed a small-for-gestational-age fetus weighing 1180 g, percentile 5th compared to Hadlock, and decreased cerebroplacental ratio (CPR) index. Additionally, US findings revealed intra-abdominal fluid collection located at the liver-kidney cavity space of 27 mm and colon cavity space of 34 mm. Her electrocardiogram (ECG) showed a tachycardia. The chest X-ray revealed a pulmonary opacification without pleural effusion and fluid collection in the left lung on the first day and throughout both sides of the lung on the second day. The image suggested a pneumonia rather than an acute pulmonary edema.

Table 1 Characteristics of the patient

Characteristics	Reference value	At hospitalization	Before surgery	First day after CS	Second day after CS	Third day after CS	After 4 days from the onset	
Clinical symptoms	General status	Unremarkable	Remarkable	Remarkable	Average	Altered	Deteriorated	Normal	
Blood pressure at maximum (mmHg)	< 140/90	200/100	160/90	154/105	118/77	131/86	128/88	
Pulse rate (bpm/min)	< 90	90	121	99	118	100	100	
Respiratory rate (beats/min)	< 18	23		20	25	29	20	
SPO2 (%)	95–100	93	94	98	88–92	98	99	
Body temperature (degree Celsius)	36–37	37.0	37.0	36.5	37.0	37.1	37.0	
Symptoms	None.	Headache and epigastric pain.	Headache and epigastric pain.	-Gum hemorrhage

-Subcutaneous hemorrhage on the right hand.

	-Blurred vision

-Tired.

	-Confusional state.

-No response to stimulation

-Glassgow of 3 points.

	Unremarkable.	
Laboratory tests	PLT (109/L)	172–378	41	46	214	203	180	201	
Hemoglobin (g/L)	108–164	126	132	93	89	86	95	
Hct (L/L)	0.35–0.51	0.373	0.384	0.274	0.252	0.263	0.281	
WBC (109/L)	3.37–8.38	15.06	13.07	21.46	22.7	17.2	12.49	
Neu (%)	39.8–70.5	85.7	84.1	88.1	84.1	81.5	65.7	
AST (SGOT) (U/L)	< 35	1325	-	165.8	70.24	-	-	
ALT (SGPT) (U/L)	< 35	600	-	167.6	102.10	-	43.01	
Total bilirubin (µmol/L)	< 15	76.17	-	24.24	11.99	-	64.86	
Direct bilirubin (µmol/l)	< 5	34.86	-	9.19	7.80	-		
Albumin (g/l)	35–52	30.11	-	-	27.03	27.1	28.22	
Protid		62.88						
Na+	136–146	133.4	-	126	128.9	136	138.5	
K+	3.4–4.5	3.54	-	2.9	4.29	3.78	3.20	
Ca++	2.20–2.65	2.17	-	0.63	1.78	1.62	2.04	
Chlorid−	101–109	100.7	-	-	95.9	103.8	102.9	
Mg++	0.77–1.03	2.17	-	-	2.88	2.30	0.66	
Management	Obstetric indication	Monitoring.	IOL and CS due to non-assuring FHR.	Postoperative follow-up at reanimation room.	Postoperative follow-up at reanimation room.	Postoperative follow-up at reanimation room.	Consultation with a neurologist

and requiring a MRI.

	Postoperative follow-up at ward.	
Medical treatment	-Anticonvulsive

(MgSO4)

-Antihypertensive

(Nicardipine)

-Antibiotic

(cephotaxin, vinphacin)

	-Anticonvulsive

(MgSO4)

-Antihypertensive

(Nicardipine)

-Antibiotic

(cephotaxin, vinphacin)

	-Anticonvulsive

(MgSO4)

-Antihypertensive

(Nicardipine)

-Antibiotic

(cephotaxi, vinphacin)

	-Anticonvulsive

(MgSO4)

-Antihypertensive

(Nicardipine)

-Antibiotic

(cephotaxin, vinphacin)

-Oxygen support via cannula

	-Maintenance of

Anticonvulsive

-Antihypertensive

-Antibiotic modification (imipenem, levofloxacin)

- Oxygen support via cannula

	-Antiepileptic therapy including

haloperidol 2 mg twice a day and

levetiracetam 500 mg twice a day.

	-Antiepileptic

Haloperidol 2 mg twice a day

-Levetiracetam 500 mg twice a day

	
ALT: alanine aminotransferase, AST: aspartate transaminase, CS: cesarean section, FHR: fetal heart rate, IOL: induction of labor, MgSO4: magnesium sulfate, MRI: magnetic resonance imaging, PLT: platelet, Hct: hematocrit, SGOT: serum glutanic-oxaloacetic transaminase, SGPT: serum glutamic pyruvic transaminase, WBC: white blood count

In the present case, the patient was initially diagnosed with HELLP syndrome secondary to severe preeclampsia. The anticonvulsive, antihypertensive, and antibiotic therapy was immediately administered. After the first dose of fetal lung maturation therapy with corticosteroid administration, the termination of pregnancy was indicated with induction of labor using Foley balloon catheter insertion. However, due to non-reassuring fetal heart rate, the pregnant woman underwent an emergent cesarean section under general anesthesia. The patient received one packed platelet (6 units, 40 ml/unit) before surgery. The amniotic fluid collection was 100 ml and the estimated blood loss was 300 ml. IM Oxytocin 10UI was used for the uterotonic and 40UI-oxytocin-IV infusion maintenance and IM-Duratocin 100 mcg was used for the prevention of postpartum hemorrhage (PPH). The female neonate was 950 g in weight and recorded 5 points at 1 min and 7 points at 5 min. The newborn was sent to the neonatal intensive care unit (NICU).

The second day after cesarean delivery, the hemodynamic condition and laboratory tests were stable, except for low hemoglobin levels. The arterial blood gas result showed a normal acid-base balance. Procalcitonin was at 1.3 ng/ml. The patient was noted with apyrexia. Urine output was within normal limits. However, the patient developed rapidly mental disorders with headaches, altered sensorium, visual disturbances, and other focal deficits. On day postoperative 4, the patient received one unit of red blood cell packed transfusion (350 ml), the blood group of B+.

A consultation with a neurologist was required and brain magnetic resonance imaging (MRI) was performed. The neuroimaging findings revealed chronic sinusitis and otomastoiditis. Noticely, MRI demonstrated an homogenous low- to iso-signal intensity on T1-weighted images and diffuse symmetrical high-signal intensity lesions on T2 weighted image (T2WI) and T2 Flair involving white matters of bilateral parieto-occipital lobes and lenticular nucleus suggestive of PRES (Fig. 1). No mass lesion was detected at cerebellum and brainstem on T1WI, T2WI, and T2 Flair. Using three-dimensional time-of-flight (3D-TOF) MR angiography, no arteriovenous malformation was oberved. Immediately, the treatment was started with oral antiepileptic drugs including haloperidol 2 mg twice a day and levetiracetam 500 mg twice a day. The patient recovered gradually and the clinical condition improved after 5 days of a strict managment. The patient was monitored for 3 months without neurological permanent damage.

Fig. 1 The axial plane of brain MRI shows the chronic sinusitis and otomastoiditis (A) and the symmetrically cortical and subcortical lesions implementing the white matter structures of bilateral parieto-occipital lobes and lenticular nucleus demonstrates typical damages of PRES in the present case (B)

Discussion

In this pregnant woman, the patient had sufficiently the criteria for early-onset preeclampsia before 34 weeks of gestation including a pregnancy-related hypertension ≥ 140/90 mmHg measuring at many timepoints and a proteinuria ≥ 300 mg/24 hour. Importantly, the HELLP syndrome was also identified with impaired liver function and thrombocytopenia [12].

Particularly, the patients was noted with abnormal lung sounds, a low saturation of peripheral oxygen (SpO2) of 93% and an imaging of patchy alveolar infiltrates on the chest X-ray. These characteristics may be overlapped with acute pulmonary edema in severe preeclampsia and should be firstly excluded. However, the SpO2 increased rapidly to 98% with oxygen support. This well-responded feature may be different from acute respiratory distress relating to pulmonary edema. The sudden manifestation of lung edema develops rapidly since alveoli filled with fluid that requires alternatively a high-flow oxygen therapy, continuous positive airway pressure delivered by face mask, even intubation and mechanical ventilation [13–15]. In severe preeclampsia, the underlying mechanism of pulmonary edema is due to increased capillary hydrostatic pressure. Therefore, hypertensive therapy and diuretic agent should be used in this hemodynamic disorder [16]. Whilst, the chest X-ray did not reveal an abnormal accumulation of fluid in the lung. Moreover, the pregnant woman had a cough symptom with green phlegm before the onset of hypertension. Although the patient was afebrile, the blood count test before surgical intervention showed a high white blood count of 15.06 × 109/L and neutrophile of 85.7%. Therefore, these changes suggested an infectious manifestation originated from the lung.

Classically, a clinical presentation with seizures and focal neurological deficit in puerperium has a wide differential diagnosis. Until 2019, the literature included 47 cases implementing on the posterior reversible encephalopathy syndrome (PRES) in pregnancy [3]. This transient clinical condition is not well known and probably underdiagnosed. The symptoms may be indistinguishable and shared with preeclampsia. In 2022, among 53 pregnant women with preeclampsia and eclampsia, Bahadur et al. found that 12 patients were diagnosed with eclampsia and developed to PRES. Among 12 patients suspected of PRES on the clinical aspect, 9 cases had evidence on the imaging tool. Eclampsia was found in the independent predictor of PRES (odds ratio, OR 20.9; 95% confidence interval, CI 3.0-147.0, p = 0.02) [17].

In 2023, Tawati et al. found 200 cases relating to preeclampsia and eclampsia. Among 342 women with eclampsia who had neuroimaging, 176 cases (51.4%) were diagnosed with PRES. Of 121 pregnant women with severe preeclampsia, 24 cases (19.8%) had PRES [18]. Almost all cases of PRES occur predominantly among women accompanying with gestational-induced hypertension disorders. However, PRES could also be presented in a pregnant woman without hypertension [19].

In our case, the patient was initially suspected of the neurological complications after a severe preeclampsia. However, the hypertension and laboratory tests were stable after the termination of pregnancy following the context of severe preeclampsia. Therefore, a different diagnosis of brain damage was made and an MRI was indicated immediately after an interdisciplinary consultation. The diagnosis of PRES was identified by specific images in associated with posterior-circulation predominant vasogenic edema [5]. Accordingly, involving regions consists of frontal lobe (72%), temporal lobe (67%), basal ganglia (50%), cerebellum (47%), brain stem (14%), and thalamus (8%). In addition, atypical neuroimaging findings included restricted diffusion (33%), contrast enhancement (19%), and hemorrhage (19%) [7].

Although the gold standard of PRES diagnosis is brain autopsy, this is only performed after the patient’s death. Some factors enhanced the development of PRES in the present case including severe preeclampsia, HELLP syndrome, and pulmonary infection. These comorbidities have been demonstrated in the literature [7].

Seriously, a permanent brain damage can occur if the diagnosis and treatment are delayed [20]. A proper management with multidisciplinary care is strongly recommended in this pathology [10]. In addition to hypertensive treatment, antiepileptic and anticonvulsive therapies are highly effective in this syndrome (Table 2).

Table 2 Summary of PRES in pregnancy in the last 5-year literature

Authors, year, country	Maternal age	Gravida,
Parity	GA	History of disease	Symptoms	Diagnosis on MRI/CT scan	Timepoint of onset	Interventions	Treatment
time	Recovery time	Outcomes	
Marcoccia et al., 2019, Italia [3]	21 yo	Primigravida.	39w.	Healthy.	Hypertension, severe headache and generalized tonic-clonic seizure, alertness, mydriasis, and decrease in visual acuity, bilateral blindness.	Bioccipital foci of high signal intensity involving the cortex and subcortical white matter with normal DWI.	On the first day after

CS for breech presentation.

	-Antiepileptic + Antihypertensive treatment

-Mannitol

	In 24 h.	On day postoperative 10.	No ophthalmological and neurological permanent damage persisted after 1-year follow-up.	
29 yo	Primigravida.	40w3d.	Healthy.	Severe headache, hypertension and a generalized tonic-clonic seizure.	Cerebellar and occipital foci of high signal intensity involving the cortex and subcortical white matter with normal DWI.	Early puerperium.	Phenytoin urapidil and alfametildopa.	In postpartum day 7.	-	Alive.	
43 yo	G1P0.	37 w.	-Gestational hypertension.

-Gilbert’s syndrome.

	-Headaches.

-Severe epigastric pain.

-Generalized tonic-clonic seizure.

	Cortical and subcortical hyperintense lesions in both cerebellar lobes with elevated diffusion and no angiopathy.	Five hours after delivery.	-Diazepam.

-MgSO4.

	In 24 h after the onset.	20th day after delivery.	Total recovery.	
Zhang et al., 2022, China [19]	32 yo	Primigravida.	25w4d.	Healthy.	Intermittent headache, hearing loss, memory loss

mental and behavioral disorder, and blurred vision for 1 month.

	Diffuse symmetrical high-signal intensity lesions in the white matter, medulla oblongata, without enhancement.	Second trimester.	-Treatment with mannitol, dexamethasone (10 mg/d), and low molecular.

-Termination of pregnancy by CS.

	On the day of admission.	Complete recovery at postoperative 6 months.	Alive

without any neurological sequelae.

	
Katwall et al., 2023, Nepal [18]	30 yo	G3P2.	38w.	Gestational hypertension.	Sudden headache.	Bilateral frontoparietal white matter edema, consistent with PRES.	After vaginal delivery with IOL

1st day of postpartum.

	-Analgesics.

-Close monitoring.

	In 24 h.	Within a week.	Recovery.	
Our indexed report	31 yo	G3P2.	29 w 5 d.	None.	-Blurred vision.

-Mental disorders.

		After the first day of CS.	Antiepileptic.	In 24 h after onset.	After 5 days.	Alive

Recovery without sequelae.

	
CS: cesarean section, D: day, DWI: Diffusion Weighted Images, IOL: induction of labor, MgSO4: magnesium sulfate, MRI: magnetic resonance imaging, PRES: posterior reversible encephalopathy syndrome, Yo: years old, W: week

Conclusions

In the puerperium, posterior reversible encephalopathy syndrome (PRES) is an uncommon pathology with a broad range of clinical symptoms. When eclampsia is ruled out, the presence of mental illnesses in pregnant women with predisposing-risk factors including HELLP syndrome and severe preeclampsia should be taken into consideration as PRES. The cranial imaging modalities such as MRI, CT scan are widely accepted among pregnant women diagnosed with severe preeclampsia followed by abnormally neurological manifestations. A high index of recognition with an interdisciplinary assessment facilitates substantially the rate of recovery. Future studies are necessary to report the PRES outcomes and strengthen the timely indication of radiologic imagings for pregnant women with neurological symptoms and severe preeclampsia.

Acknowledgements

We thank the patient and her family, who agreed to allow us to publish the clinical data. The authors are also grateful for all colleagues working at the Department of High-risk Pregnancy and the Department of Anesthesia and Reanimation. We thank directly to Hoa Hao Medic Center for the MRI images. We also thank other colleagues working at Tu Du Hospital. All of them provided us with great pictures, took care of the patient, and directly performed the cesarean section.

Author contributions

A.D.B.V. and X.T.T.P. were involved in patient care, collection of the information, and administrative procedures. P.N.N. contributed to be responsible for administrative procedures, to receiving information, collecting the data, writing, editing, and revising the manuscript. P.N.N. was the guarantor of this work. All authors read and approved the final manuscript.

Funding

No funding was required in the preparation of the manuscript.

Data availability

No datasets were generated or analysed during the current study.

Declarations

Ethical approval

Ethics approval was naturally waived for case reports by the ethics committee of Tu Du Hospital. The study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.

Consent to participate

Written informed consent was obtained from the participant.

Consent for publication

Written informed consent was obtained from the patient for publication of this study and accompanying images.

Competing interests

The authors declare no competing interests.

Abbreviations

CT scan computed tomography scan

MRI Magnetic resonance imaging

HELLP Hemolysis, elevated liver enzymes, and low platelets

PRES Posterior reversible encephalopathy syndrome

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Anh Dinh Bao Vuong and Phuc Nhon Nguyen contributed equally to this work and share the first authorship.
==== Refs
References

1. Pilato F Distefano M Calandrelli R Posterior reversible Encephalopathy Syndrome and reversible cerebral vasoconstriction syndrome: clinical and radiological considerations Front Neurol 2020 11 34 10.3389/fneur.2020.00034 32117007
Pilato F, Distefano M, Calandrelli R. Posterior reversible Encephalopathy Syndrome and reversible cerebral vasoconstriction syndrome: clinical and radiological considerations. Front Neurol. 2020;11:34.32117007 10.3389/fneur.2020.00034
2. Min Z Gnann JW Reversible posterior leukoencephalopathy syndrome Intern Emerg Med 2014 9 3 341 2 10.1007/s11739-013-1011-1 24132656
Min Z, Gnann JW. Reversible posterior leukoencephalopathy syndrome. Intern Emerg Med. 2014;9(3):341–2.24132656 10.1007/s11739-013-1011-1
3. Marcoccia E Piccioni MG Schiavi MC Colagiovanni V Zannini I Musella A Postpartum posterior reversible Encephalopathy Syndrome (PRES): three Case reports and Literature Review Case Rep Obstet Gynecol 2019 2019 9527632 30809401
Marcoccia E, Piccioni MG, Schiavi MC, Colagiovanni V, Zannini I, Musella A, et al. Postpartum posterior reversible Encephalopathy Syndrome (PRES): three Case reports and Literature Review. Case Rep Obstet Gynecol. 2019;2019:9527632.30809401
4. Ansari B Saadatnia M Prevalence and risk factors of posterior reversible Encephalopathy Syndrome in Isfahan, Iran Adv Biomedical Res 2021 10 53 10.4103/abr.abr_243_19
Ansari B, Saadatnia M. Prevalence and risk factors of posterior reversible Encephalopathy Syndrome in Isfahan, Iran. Adv Biomedical Res. 2021;10:53.10.4103/abr.abr_243_19
5. Anderson RC Patel V Sheikh-Bahaei N Liu CSJ Rajamohan AG Shiroishi MS Posterior reversible Encephalopathy Syndrome (PRES): pathophysiology and neuro-imaging Front Neurol 2020 11 463 10.3389/fneur.2020.00463 32612567
Anderson RC, Patel V, Sheikh-Bahaei N, Liu CSJ, Rajamohan AG, Shiroishi MS, et al. Posterior reversible Encephalopathy Syndrome (PRES): pathophysiology and neuro-imaging. Front Neurol. 2020;11:463.32612567 10.3389/fneur.2020.00463
6. Triplett JD Kutlubaev MA Kermode AG Hardy T Posterior reversible encephalopathy syndrome (PRES): diagnosis and management Pract Neurol 2022 22 3 183 35046115
Triplett JD, Kutlubaev MA, Kermode AG, Hardy T. Posterior reversible encephalopathy syndrome (PRES): diagnosis and management. Pract Neurol. 2022;22(3):183.35046115
7. Wen Y Yang B Huang Q Liu Y Posterior reversible encephalopathy syndrome in pregnancy: a retrospective series of 36 patients from mainland China Ir J Med Sci 2017 186 3 699 705 10.1007/s11845-017-1567-2 28155100
Wen Y, Yang B, Huang Q, Liu Y. Posterior reversible encephalopathy syndrome in pregnancy: a retrospective series of 36 patients from mainland China. Ir J Med Sci. 2017;186(3):699–705.28155100 10.1007/s11845-017-1567-2
8. Shankar J Banfield J Posterior reversible Encephalopathy Syndrome: a review Can Assoc Radiol J 2017 68 2 147 53 10.1016/j.carj.2016.08.005 28131335
Shankar J, Banfield J. Posterior reversible Encephalopathy Syndrome: a review. Can Assoc Radiol J. 2017;68(2):147–53.28131335 10.1016/j.carj.2016.08.005
9. Sheikh-Bahaei N Acharya J Rajamohan A Kim PE Advanced Imaging Techniques in diagnosis of posterior reversible Encephalopathy Syndrome (PRES) Front Neurol 2020 11 165 10.3389/fneur.2020.00165 32218764
Sheikh-Bahaei N, Acharya J, Rajamohan A, Kim PE. Advanced Imaging Techniques in diagnosis of posterior reversible Encephalopathy Syndrome (PRES). Front Neurol. 2020;11:165.32218764 10.3389/fneur.2020.00165
10. Hobson EV Craven I Blank SC Posterior reversible encephalopathy syndrome: a truly treatable neurologic illness Perit dialysis International: J Int Soc Perit Dialysis 2012 32 6 590 4 10.3747/pdi.2012.00152
Hobson EV, Craven I, Blank SC. Posterior reversible encephalopathy syndrome: a truly treatable neurologic illness. Perit dialysis International: J Int Soc Perit Dialysis. 2012;32(6):590–4.10.3747/pdi.2012.00152
11. Ismail FS van de Nes J Kleffner I A broad spectrum of posterior reversible encephalopathy syndrome - a case series with clinical and paraclinical characterisation, and histopathological findings BMC Neurol 2021 21 1 386 10.1186/s12883-021-02408-0 34615476
Ismail FS, van de Nes J, Kleffner I. A broad spectrum of posterior reversible encephalopathy syndrome - a case series with clinical and paraclinical characterisation, and histopathological findings. BMC Neurol. 2021;21(1):386.34615476 10.1186/s12883-021-02408-0
12. Poon LC Magee LA Verlohren S Shennan A von Dadelszen P Sheiner E A literature review and best practice advice for second and third trimester risk stratification, monitoring, and management of pre-eclampsia: compiled by the pregnancy and Int J Gynaecol Obstet 2021 154 1Suppl 1 3 31 10.1002/ijgo.13763 34327714
Poon LC, Magee LA, Verlohren S, Shennan A, von Dadelszen P, Sheiner E, et al. A literature review and best practice advice for second and third trimester risk stratification, monitoring, and management of pre-eclampsia: compiled by the pregnancy and. Int J Gynaecol Obstet. 2021;154(1Suppl 1):3–31. Non-Communicable Diseases Committee of FIGO (the International Federation of Gynecology and Obstetrics.34327714 10.1002/ijgo.13763
13. Yokoyama T Kondoh Y Tasaka S Noninvasive ventilation and high-Flow Oxygen Therapy for ARDS: does Noninvasive Ventilatory Management improve the outcome of ARDS patients? Acute respiratory distress syndrome: advances in Diagnostic tools and Disease Management 2022 Singapore Springer Nature Singapore 89 103
Yokoyama T, Kondoh Y. Noninvasive ventilation and high-Flow Oxygen Therapy for ARDS: does Noninvasive Ventilatory Management improve the outcome of ARDS patients? In: Tasaka S, editor. Acute respiratory distress syndrome: advances in Diagnostic tools and Disease Management. Singapore: Springer Nature Singapore; 2022. pp. 89–103.
14. Cutuli SL Grieco DL Menga LS De Pascale G Antonelli M Noninvasive ventilation and high-flow oxygen therapy for severe community-acquired pneumonia Curr Opin Infect Dis 2021 34 2 142 50 10.1097/QCO.0000000000000715 33470666
Cutuli SL, Grieco DL, Menga LS, De Pascale G, Antonelli M. Noninvasive ventilation and high-flow oxygen therapy for severe community-acquired pneumonia. Curr Opin Infect Dis. 2021;34(2):142–50.33470666 10.1097/QCO.0000000000000715
15. Ko DR, Beom J, Lee HS, You JS, Chung HS, Chung SP. Benefits of High-Flow nasal cannula therapy for Acute Pulmonary Edema in patients with heart failure in the Emergency Department: a prospective Multi-center Randomized Controlled Trial. J Clin Med. 2020;9(6).
16. Ram M Anteby M Weiniger CF Havakuk O Gilboa I Shenhav M Acute pulmonary edema due to severe preeclampsia in advanced maternal age women Pregnancy Hypertens 2021 25 150 5 10.1016/j.preghy.2021.05.019 34144403
Ram M, Anteby M, Weiniger CF, Havakuk O, Gilboa I, Shenhav M, et al. Acute pulmonary edema due to severe preeclampsia in advanced maternal age women. Pregnancy Hypertens. 2021;25:150–5.34144403 10.1016/j.preghy.2021.05.019
17. Bahadur A Mundhra R Singh R Mishra J Suresh G Jaiswal S Predictors of posterior reversible Encephalopathy Syndrome (PRES) in women with Pre-eclampsia/Eclampsia: a retrospective analysis Cureus 2022 14 11 e31459 36523680
Bahadur A, Mundhra R, Singh R, Mishra J, Suresh G, Jaiswal S, et al. Predictors of posterior reversible Encephalopathy Syndrome (PRES) in women with Pre-eclampsia/Eclampsia: a retrospective analysis. Cureus. 2022;14(11):e31459.36523680
18. Katwal S Ghimire A Bhusal A Bajracharya A Posterior reversible encephalopathy syndrome in postpartum patients with gestational hypertension: a case report emphasizing early recognition and management Radiol Case Rep 2023 18 12 4564 8 10.1016/j.radcr.2023.09.068 37886729
Katwal S, Ghimire A, Bhusal A, Bajracharya A. Posterior reversible encephalopathy syndrome in postpartum patients with gestational hypertension: a case report emphasizing early recognition and management. Radiol Case Rep. 2023;18(12):4564–8.37886729 10.1016/j.radcr.2023.09.068
19. Zhang Y, Liang B, Zhao C, Zhou Y, Yan C. Posterior reversible encephalopathy in a pregnant woman without preeclampsia or eclampsia: a case report. Medicine. 2022;101(36).
20. Ando Y Ono Y Sano A Fujita N Ono S Posterior reversible Encephalopathy Syndrome: a review of the literature Intern Med (Tokyo Japan) 2022 61 2 135 41 10.2169/internalmedicine.7520-21
Ando Y, Ono Y, Sano A, Fujita N, Ono S. Posterior reversible Encephalopathy Syndrome: a review of the literature. Intern Med (Tokyo Japan). 2022;61(2):135–41.10.2169/internalmedicine.7520-21
